The pharma industry briefing

The latest news, approvals and clinical trials you need to know about this month

Data:
News
in Numbers

100  

More than 100 children died in an outbreak of suspected encephalitis in India's Bihar state, according to officials

 $11.4bn 

Pfizer has a made a $48 per share play for Array Biopharma, which values the cancer specialist at $11.4 billion

$225 million 

The potential price tag of Novartis’ new gene therapy drug, Zolgensma

Eight 

Two pharmaceutical manufacturing facilities (one in India and one in China) have suffered explosions in just eight weeks, resulting in multiple fatalities

107

The number of generic drugs that Teva Pharmaceutical’s former senior vice president Maureen Cavanaugh has been accused of colluding to raise prices on

Data:
News
in Numbers

100

More than 100 children died in an outbreak of suspected encephalitis in India's Bihar state, according to officials

$11.4bn  

Pfizer has a made a $48 per share play for Array Biopharma, which values the cancer specialist at $11.4 billion

Eight

Explosions at two pharmaceutical manufacturing facilities (one in China and one in India) have resulted in fatalities in just eight weeks

107

The number of generic drugs that Teva Pharmaceutical’s former senior vice president Maureen Cavanaugh has been accused of colluding to raise prices on

$225 million 

The amount that Insys Therapeutics has agreed to pay to end to end criminal and civil investigations

  DHL invests $150M to expand pharma, medical supply chain

DHL Supply Chain plans to invest $150 million to expand its distribution network of medical devices and pharmaceutical supplies.

Source: Supply Chain Dive

Survey shows crisis of confidence in vaccines in parts of Europe

A global survey of attitudes towards science has revealed the scale of the crisis of confidence in vaccines in Europe, showing that only 59% of people in western Europe and 50% in the east think vaccines are safe, compared with 79% worldwide.

Source: Guardian

 Push to develop world’s first vaccine against the deadly Strep A bacteria

The British biomedical research foundation, the Wellcome Trust, has granted $2.25m to IVI & MCRI to coordinate efforts to develop world’s first vaccine against Strep A bacteria.

Source: Health Europa

Celgene dips out of deals ahead of mega-merger

Celgene has agreed to pay $150m to exit a two-year-old deal with BeiGene focused on developing and commercializing one of the Chinese biotech's immuno-oncology drugs.

Source: Bio Pharma Dive

AstraZeneca plans $630m Korea investment amid favourable policies

AstraZeneca is set to spend $630m on R&D in South Korea over the next five years. The commitment is part of a wider agreement between organizations in Korea and Sweden.

Source: Fierce Biotech

Approvals

NAYZILAM® (midazolam)

The US FDA has approved a New Drug Application for the UCB’s newest anti-epileptic drug (AED) NAYZILAM® (midazolam) nasal spray CIV.

Source: UCB

Zolgensma 

The US FDA has approved Novartis AG’s Zolgensma, a gene therapy targeting children under two years old who have a severe illness called spinal muscular atrophy. 

Source: FDA

Polivy (polatuzumab vedotin-piiq)

The US FDA has approved an antibody-drug conjugate to treat people with diffuse large B-cell lymphoma

Source: Cancer.org

Rozlytrek

Roche's personalised cancer drug Rozlytrek has been approved by regulators in Japan.

Source: Reuters

Go to top

Share this article